期刊文献+

DCP和AFP-L3在AFP低浓度原发性肝癌诊断中的意义 被引量:4

Significance of DCP and AFP- L3 expression in primary hepatocellular carcinoma with low level of AFP
原文传递
导出
摘要 目的探讨血清中脱γ-羧基凝血酶原(DCP)和甲胎蛋白异质体(AFP-L3)对低浓度AFP原发性肝细胞癌(PHC)的应用价值。方法采收集51例低浓度AFP PHC患者、52例非肝癌患者和101例健康对照者的血清分别检测DCP和AFP-L3,并对其统计分析。结果低浓度AFP PHC患者的DCP和AFP-L3阳性率显著高于非肝癌和健康对照者(P<0.05),而非肝癌组和健康对照组两者差异无统计学意义(P>0.05)。DCP和AFP-L3诊断低浓度AFP PHC的灵敏度分别为76.47%(39/51)和70.59%(36/51),特异性分别为96.08%(147/153)和94.12%(144/153)。两项串联检测时,其诊断的特异性略微提高至98.69%(151/153),并联检测时敏感度显著提高至90.20%(46/51)。结论DCP和AFP-L3对低浓度AFP PHC患者具有较强的诊断效能,两项并联检测能有效避免一些漏检病例。 Objective To explore the clinical value of des - gamma carboxyprethrombin ( DCP), and alpha - fetoprotein - L3 ( AFP - L3) ) in diagnosing primary liver cancer (PHC) with low level of AFP. Methods The DGP and AFP - L3 were detec- ted in 51 cases of primary liver cancer, 52 cases of liver cirrhosis and chronic hepatitis B, and 101 healthy controls. The SPSS statistical software was used for statistical analysis. Results The positive rate of DCP and AFP - L3 were significant higher in primary liver cancer with low level of AFP group than other groups (P 〈 0.05 ), and no difference between other liver disease group,and healthy control group. The sensitivity of DCP and AFP -L3 were 76.47% and 70.59%, respectively; the specificity were 96.08% and 94.12%, respectively. The sensitivity and specificity of combined detection of the two parameters were high- er than detection of only one parameter. Condusion The DCP and AFP - L3 have very important meaning in the diagnosis for PHC with low concentration AFP; combined detection of them can avoid in some missing cases.
出处 《中国卫生检验杂志》 北大核心 2014年第17期2538-2540,共3页 Chinese Journal of Health Laboratory Technology
关键词 脱γ-羧基凝血酶原 甲胎蛋白异质体 原发性肝癌 Des - gamma carboxyprothrombin Alpa fetoprotein - L3 Primary hepatocellular carcinoma
  • 相关文献

参考文献11

二级参考文献49

  • 1青柳豊,韩少良.甲胎蛋白(AFP)L3组分[J].日本医学介绍,2005,26(2):49-50. 被引量:37
  • 2董怀平,王力,赵岐刚,张延强,李庆敏.AFU、AFP-L3、HCY联合检测对原发性肝癌早期诊断临床价值的研究[J].中国实验诊断学,2007,11(4):485-487. 被引量:18
  • 3万文徽,李吉友.肿瘤标志的临床应用[J].中华医学检验杂志,1997,20(1):49-51. 被引量:180
  • 4孟宪镛.小肝癌诊断和治疗现状[J].新消化病学杂志,1997,5(5):273-274. 被引量:9
  • 5Sterling RK,Jeffers L,Cordon F,et al.Utility of Lens culinaris agglu-tinin-reactive fraction of alpha-fetoprotein and des-gamma-cazboxy prothrombin,alone or in combination,as biomarkers for hepatocellular carcinoma.Clin Gastroenterol Hepatol,2009,7(1):104-113.
  • 6Zinkin NT,Grail F,Bhaskar K,et al.Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.Clin Cancer Res,2008,14(2):470-477.
  • 7Carr BI,Kanke F,Wise M,et al.Clinical evaluation of lens culinaris agglutinin-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin in histologically proven hepatocellular carcinoma in the United States.Dig Dis Sci,2007,52(3):776-782.
  • 8Volk ML,Hernandez JC,Su GL,et al.Risk factors for hepatocellular carcinoma may impair the performance of biomarkers:a comparison of AFP,DCP,and AFP-L3.Cancer Biomark,2007,3(2):79-87.
  • 9万文徽.血清中AFP、CA19-9、AFU、TGF-β1联合检测在肝癌诊断中的价值//肿瘤标志临床应用与研究.2版.北京:北京大学医学出版社,2007:9.
  • 10Marrero JA,Romano PR,Nikolaeva O,et al.GP73,a resident Golgi glycoprotein,is a novel serum marker for hepatocellular carcinoma.J Hepatol,2005,43:1007-1012.

共引文献105

同被引文献52

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部